Pharmacist Prescribing Matches or Beats Usual Care Across Settings

This systematic review consolidates 39 studies to show that pharmacist prescribing produces effectiveness and safety outcomes equivalent to or better than physician prescribing across diverse chronic disease settings, though the underlying evidence is of low to very low certainty.

📅 Journal publication: Jun 25, 2026 · Last updated: Jul 30, 2026

pharmacist prescribingcollaborative practice agreementindependent prescribingdeprescribinganticoagulationdiabeteshypertensionsystematic reviewambulatory carescope of practice Ambulatory Care / MTM

Background Information

Pharmacists prescribing may enhance care efficiency and outcomes.

Pharmacist prescribing can expand healthcare access and streamline care, crucial as healthcare demands increase. Out of 153 outcomes, 46 showed improved results with pharmacist prescribing, while 74 showed no difference in effectiveness and safety compared to non-pharmacist prescribing. The evidence suggests pharmacist prescribing is as effective and safe as traditional models, but the low evidence certainty limits broad implementation recommendations. Pharmacist prescribing shows promise in enhancing healthcare outcomes and access.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.

Subscribe for $8/month → Read this one free →

Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Teahan Á, Sharp M, Farragher A, Strawbridge J, Long J

Citation: Teahan Á, Sharp M, Farragher A, et al. Effectiveness and safety of pharmacist prescribing: a systematic review. BMJ open. 2026;16(6):e112886. doi:10.1136/bmjopen-2025-112886

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Founding member rate

$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →

Free account, no credit card. Includes 1 full deep analysis every month.

Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.